Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NASH
NASH
Bioclinica wants to move the needle in NASH
Fierce Biotech
Tue, 04/23/19 - 09:59 am
Bioclinica
NASH
Medical Imaging
Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay
EP Vantage
Sat, 04/13/19 - 12:23 pm
Amgen
Enbrel
CymaBay
NASH
Erelzi
seladelpar
Genfit
Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs
TheStreet.com
Fri, 04/12/19 - 10:05 am
NASH
Gilead Sciences
Novo Nordisk
clinical trials
Intercept Tries to Outrun Pharma in Race for the Next Blockbuster
Bloomberg
Thu, 04/11/19 - 07:27 pm
liver disease
NASH
Intercept Pharmaceuticals
OCA
obeticholic acid
Gilead shores up hope for NASH cocktail with a glimpse at positive proof-of-concept data
Endpoints
Thu, 04/11/19 - 12:33 pm
Gilead Sciences
NASH
cilofexor
firsocostat
selonsertib
NASH-focused medtech company DIAFIR appoints Mr. Richard Guillaume to its BOD
CP Wire
Mon, 04/8/19 - 12:22 am
NASH
DIAFIR
NASH-focused medtech company DIAFIR appoints Mr. Richard Guillaume to its BOD
Mon, 04/8/19 - 12:21 am
NASH
DIAFIR
2 Biotechs With Big Dates in April
Motley Fool
Sat, 03/30/19 - 01:04 pm
Alnylam
EASL
Intercept Pharmaceuticals
Onpattro
givosiran
NASH
Ocaliva
Pfizer squeezes out positive data for fructose-fighting NASH drug
Biopharma Dive
Fri, 03/29/19 - 10:16 am
Pfizer
NASH
clinical trials
Multi-Dose NASH Clinical Trial Underway for Durect’s DUR-928
Xtalks
Fri, 03/29/19 - 10:03 am
Durect Corporation
NASH
DUR-928
GenFit gets $135M Nasdaq IPO for NASH, PBC hopes
Fierce Biotech
Wed, 03/27/19 - 10:21 am
Genfit
IPOs
NASH
primary biliary cholangitis
NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million
CP Wire
Tue, 03/26/19 - 09:38 am
NGM Biopharmaceuticals
IPOs
Merck
NASH
NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million
Tue, 03/26/19 - 09:30 am
NGM Biopharmaceuticals
IPOs
Merck
NASH
Conatus and Novartis suffer another midphase NASH flop
Fierce Biotech
Fri, 03/22/19 - 11:51 am
Conatus
Novartis
NASH
emricasan
clinical trials
Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan
Yahoo/Zacks.com
Thu, 03/21/19 - 09:47 am
Conatus
emricasan
NASH
Merck doubles down on NGM Bio pact but culls obesity drug
Fierce Biotech
Wed, 03/20/19 - 12:15 pm
Merck
R&D
NGM Biopharmaceuticals
NP201
NASH
obesity
GENFIT Seeks $132 Million IPO to Support NASH Programs
BioSpace
Fri, 03/15/19 - 10:49 am
Genfit
IPOs
NASH
Genfit files for NASDAQ listing
BioCentury
Thu, 02/28/19 - 09:58 am
Genfit
NASH
NASDAQ
Intercept stock drop reflects the high bar set for NASH drugs
BioPharma Dive
Sat, 02/23/19 - 04:52 pm
Intercept Pharma
Ocaliva
NASH
clinical trials
Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment
BioSpace
Tue, 02/19/19 - 10:24 am
NASH
Intercept Pharmaceuticals
obeticholic acid
OCA
clinical trials
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »